Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

Clinical trial NCT00396721 · COMPLETED

Trial details

NCT number: NCT00396721
Sponsor: Josep m Cruzado
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glomerulonephritis, IGA Nephropathy, IGA IGA Nephropathy

Start date: 2006-01-01
Primary completion: 2009-10-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.